Strategic Wealth Partners’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,690
Closed -$375K 1502
2025
Q4
$375K Sell
3,690
-60
-2% -$4.82K 0.03% 233
2025
Q3
$205K Hold
3,750
0.02% 331
2025
Q2
$199K Buy
+3,750
New +$191K 0.02% 315
2024
Q4
Sell
-3,750
Closed -$255K 319
2024
Q3
$255K Buy
+3,750
New +$212K 0.02% 269
2024
Q2
Sell
-3,924
Closed -$271K 294
2024
Q1
$271K Buy
3,924
+125
+3% +$7.91K 0.03% 240
2023
Q4
$281K Hold
3,799
0.03% 229
2023
Q3
$259K Sell
3,799
-47
-1% -$3.99K 0.03% 250
2023
Q2
$361K Buy
+3,846
New +$300K 0.05% 226
2021
Q1
Sell
-5,566
Closed -$737K 192
2020
Q4
$737K Sell
5,566
-14
-0.3% -$1.69K 0.31% 84
2020
Q3
$569K Buy
5,580
+3,035
+119% +$262K 0.29% 81
2020
Q2
$221K Buy
+2,545
New +$203K 0.11% 121
2019
Q4
Sell
-59
Closed -$5 243
2019
Q3
$5 Buy
+59
New +$6.72K ﹤0.01% 634

Other funds holding EXAS

Strategic Wealth Partners's EXAS Position: Q1 2026 in Review

Strategic Wealth Partners sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 3,690 shares — an estimated $375K sold.

Strategic Wealth Partners first reported a position in EXAS in Q3 2019 and held it in 12 quarters. The position peaked at $737K in Q4 2020. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Strategic Wealth Partners reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Strategic Wealth Partners sold 3,690 Exact Sciences shares in Q1 2026, an estimated $375K.
  • Strategic Wealth Partners first reported a position in Exact Sciences in Q3 2019 and held it in 12 quarters.
  • Strategic Wealth Partners's Exact Sciences position peaked at $737K in Q4 2020.
  • 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Strategic Wealth Partners's 13F filing for Q1 2026, filed 12 May 2026.